Dapoxitine-D7 HCl

Dapoxetine-D7 HCl is a deuterated analogue of dapoxetine hydrochloride, which is a short-acting selective serotonin reuptake inhibitor (SSRI). Dapoxetine-D7 HCl is primarily used as a treatment for premature ejaculation (PE) in men. PE is a common sexual dysfunction that affects up to 30% of men worldwide, causing significant distress and dissatisfaction in relationships. Dapoxetine-D7 HCl works by increasing the time it takes for ejaculation to occur, thereby improving sexual satisfaction and reducing distress. Chemically, dapoxetine-D7 HCl is a white to off-white crystalline powder that is soluble in water and ethanol. It has a molecular formula of C21H19D7ClNO2 and a molecular weight of 348.90 g/mol. The compound is stable under normal storage conditions and has a shelf life of at least two years. Dapoxetine-D7 HCl is typically administered orally in the form of tablets or capsules, with a recommended dose of 30 mg or 60 mg taken one to three hours before sexual activity. The drug is rapidly absorbed and reaches peak plasma concentration within 1-2 hours. The elimination half-life is approximately 1-2 hours, and the drug is primarily metabolized by the liver and excreted in urine. In conclusion, Dapoxetine-D7 HCl is an effective treatment for premature ejaculation that has been extensively studied and shown to be safe and well-tolerated. Its chemical properties and pharmacokinetics make it an ideal candidate for oral administration, and its short elimination half-life allows for rapid clearance and minimal accumulation in the body.